Advertisement
Screener

VANTAGE WEALTH Historic Quarter Change: Foreign Stocks, Added

VANTAGE WEALTH historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 21 quarters from 2013-06-30 to 2025-12-31, VANTAGE WEALTH opened 5 positions, added to 39, reduced 13 and sold out of 7.

  • Q3 2016: Stock RHHBY; Country of operation —; Class SPONSORED ADR; Shares before 250,869.
  • Q3 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 112,892.
  • Q3 2016: Stock NSRGY; Country of operation —; Class SPONSORED ADR; Shares before 102,837.
  • Q3 2016: Stock LRLCY; Country of operation —; Class SPONSORED ADR; Shares before 205,668.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1569174), 21 quarters: Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-14); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-11); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-09); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-01-21); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-08); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-16); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-04-09); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-10); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-12); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-13); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-11); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-06); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-05); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-08); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-12); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-30). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2012-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016RHHBY
Roche Holding AG
SPONSORED ADR250,869257,594+6,725$8,266,000$7,978,000-$288,0002016-11-10
Q3 2016NVS
Novartis AG ADR
SPONSORED ADR112,892114,850+1,958$9,315,000$9,069,000-$246,0002016-11-10
Q3 2016NSRGY
Nestle SA ADR
SPONSORED ADR102,837103,012+175$7,950,000$8,140,000+$190,0002016-11-10
Q3 2016LRLCY
L'Oreal ADR
SPONSORED ADR205,668206,518+850$7,900,000$7,804,000-$96,0002016-11-10
Q2 2016RHHBY
Roche Holding AG
SPONSORED ADR245,994250,869+4,875$7,534,000$8,266,000+$732,0002016-08-10
Q2 2016LRLCY
L'Oreal ADR
SPONSORED ADR201,643205,668+4,025$7,199,000$7,900,000+$701,0002016-08-10
Q2 2016NSRGY
Nestle SA ADR
SPONSORED ADR100,587102,837+2,250$7,505,000$7,950,000+$445,0002016-08-10
Q1 2016NVS
Novartis AG ADR
SPONSORED ADR99,629114,654+15,025$8,572,000$8,306,000-$266,0002016-05-09
Q4 2015NVS
Novartis AG ADR
SPONSORED ADR78,13899,629+21,491$7,182,000$8,572,000+$1,390,0002016-02-12
Q3 2015NSRGY
Nestle SA ADR
ADR96,86299,375+2,513$6,990,000$7,477,000+$487,0002015-11-12
Q3 2015NVS
Novartis AG ADR
SPONSORED ADR75,37878,138+2,760$7,413,000$7,182,000-$231,0002015-11-12
Q3 2015LRLCY
L'Oreal ADR
ADR191,182201,207+10,025$6,848,000$6,974,000+$126,0002015-11-12
Q3 2015RHHBY
Roche Holding AG
ADR197,314211,489+14,175$6,920,000$6,969,000+$49,0002015-11-12
Q3 2015DANOY
Danone ADR
ADR420,900428,875+7,975$5,451,000$5,404,000-$47,0002015-11-12
Q2 2015RHHBY
Roche Holding AG
ADR195,615197,314+1,699$6,725,000$6,920,000+$195,0002015-08-13
Q2 2015DANOY
Danone ADR
ADR416,700420,900+4,200$5,630,000$5,451,000-$179,0002015-08-13
Q2 2015NSRGY
Nestle SA ADR
ADR95,08796,862+1,775$7,152,000$6,990,000-$162,0002015-08-13
Q2 2015LRLCY
L'Oreal ADR
ADR187,700191,182+3,482$6,898,000$6,848,000-$50,0002015-08-13
Q2 2015NVS
Novartis AG ADR
SPONSORED ADR75,22975,378+149$7,418,000$7,413,000-$5,0002015-08-13
Q1 2015RHHBY
Roche Holding AG
ADR181,665195,615+13,950$6,175,000$6,725,000+$550,0002015-05-11
Q1 2015NSRGY
Nestle SA ADR
ADR90,76295,087+4,325$6,621,000$7,152,000+$531,0002015-05-11
Q1 2015DANOY
Danone ADR
ADR394,475416,700+22,225$5,135,000$5,630,000+$495,0002015-05-11
Q1 2015NVS
Novartis AG ADR
SPONSORED ADR74,82975,229+400$6,934,000$7,418,000+$484,0002015-05-11
Q4 2014LRLCY
L'Oreal ADR
ADR157,025188,975+31,950$4,974,000$6,299,000+$1,325,0002015-02-06
Q4 2014DANOY
Danone ADR
ADR377,900394,475+16,575$5,064,000$5,135,000+$71,0002015-02-06
Q4 2014NVS
Novartis AG ADR
SPONSORED ADR73,60474,829+1,225$6,928,000$6,934,000+$6,0002015-02-06
Q3 2014NVS
Novartis AG ADR
SPONSORED ADR72,65473,604+950$6,282,000$6,928,000+$646,0002014-11-05
Q3 2014DANOY
Danone ADR
ADR370,800377,900+7,100$5,380,000$5,064,000-$316,0002014-11-05
Q3 2014TEVA
Teva Pharmaceuticals ADR
ADR127,175128,950+1,775$6,712,000$6,931,000+$219,0002014-11-05
Q3 2014LRLCY
L'Oreal ADR
ADR153,300157,025+3,725$5,183,000$4,974,000-$209,0002014-11-05
Q2 2014DANOY
Danone ADR
ADR364,675370,800+6,125$5,175,000$5,380,000+$205,0002014-08-08
Q2 2014LRLCY
L'Oreal ADR
ADR152,825153,300+475$5,042,000$5,183,000+$141,0002014-08-08
Q1 2014TEVA
Teva Pharmaceuticals ADR
ADR132,625136,325+3,700$5,316,000$7,203,000+$1,887,0002014-05-12
Q1 2014NVS
Novartis AG ADR
SPONSORED ADR83,75483,954+200$6,732,000$7,138,000+$406,0002014-05-12
Q1 2014LRLCY
L'Oreal ADR
ADR149,625152,825+3,200$5,259,000$5,042,000-$217,0002014-05-12
Q1 2014DANOY
Danone ADR
ADR349,675364,675+15,000$5,077,000$5,175,000+$98,0002014-05-12
Q4 2013TEVA
Teva Pharmaceuticals ADR
ADR130,125132,625+2,500$4,916,000$5,316,000+$400,0002014-02-14
Q4 2013LRLCY
L'Oreal ADR
ADR146,060149,625+3,565$5,024,000$5,259,000+$235,0002014-02-14
Q4 2013DANOY
Danone ADR
ADR341,775349,675+7,900$5,140,000$5,077,000-$63,0002014-02-14

Similar Firms

Firm NameCountry13F ValueHoldings
Castle Rock Wealth Management, LLCUnited States$0.463B261
Dorsey Wright & AssociatesUnited States$0.463B132
Blankinship & Foster, LLCUnited States$0.463B79
Mudita Advisors LLPUnited Kingdom$0.463B21
ICON ADVISERS INC/COUnited States$0.463B184
MORTON COMMUNITY BANKUnited States$0.463B199
RIPOSTE CAPITAL LLCUnited States$0.462B33
Triumph Capital ManagementUnited States$0.463B1,769
KILEY JUERGENS WEALTH MANAGEMENT, LLCUnited States$0.463B74
Factor Wealth Management LTDUnited States$0.463B166